Charles M. Baum - 04 Jan 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
President,Founder,Head of R&D, Director
Signature
/s/ Reena R. Desai, Attorney-in-Fact
Issuer symbol
MRTX
Transactions as of
04 Jan 2023
Transactions value $
-$169,997
Form type
4
Date filed
05 Jan 2023, 16:13
Previous filing
21 Dec 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$170K -3.65K -2.12% $46.60 169K 04 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.